Prescribing Notes

Ulcerative colitis, Crohn's disease

Note: Different oral mesalazine formulations are designed to release active drug at different sites along the colon. Although there is no evidence that efficacy differs significantly between formulations, caution should be used if switching brands and patients should be advised to report any change in symptoms.